Skip navigation Wisconsin State Legislature
This is the preview version of the Wisconsin State Legislature site.
Please see http://docs.legis.wisconsin.gov for the production version.

Permanent Rules: Promulgation Process Completed (Rules archive prior to 1996 is not complete)

Controlled Substances Board (CSB) Stop grouping [View All]

Name
Relating Clause
  • CR 20-080 (Text)
    Relating to designating Gabapentin as a monitored drug having a substantial potential for abuse.
  • CR 20-079 (Text)
    Relating to scheduling flualprazolam.
  • CR 20-078 (Text)
    Relating to scheduling of norfentanyl.
  • CR 20-077 (Text)
    Relating to removing FDA approved cannabidiol from schedule V and excluding FDA approved cannabidiol from schedule I.
  • CR 20-076 (Text)
    Relating to scheduling of lemborexant.
  • CR 20-075 (Text)
    Relating to scheduling of cenobamate.
  • CR 20-058 (Text)
    Relating to scheduling of Lasmiditan.
  • CR 20-051 (Text)
    Relating to scheduling of noroxymorphone.
  • CR 20-050 (Text)
    Relating to scheduling of N-Ethylhexedrone, a-PHP, 4-MEAP, MPHP, PV8 and 4-chloro-a-PVP.
  • CR 20-049 (Text)
    Relating to scheduling of brexanolone and solriamfetol.
  • CR 20-048 (Text)
    Relating to scheduling of 5F-EDMB-PINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA, and FUB-144.
  • CR 20-023 (Text)
    Relating to scheduling isotonitazene and 1P-LSD.
  • CR 20-022 (Text)
    Relating to scheduling MMB-FUBICA and 4F-MDMB-BINACA.